Product: Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
Reason for recall: Failed Impurities/Degradation Specifications
Recall initiated: 20211028
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated